Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Ovid Therapeutics (1OT) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1OTOvid TherapeuticsEUR 2.30EUR 436.58M-6.2098.28%Strong BuyUnlock the DE:1OT analyst price target with TipRanks PremiumDE:1OTUnlock the DE:1OT top-analyst price target with TipRanks Premium
IRDOpus Genetics$3.98$392.42M-2.60115.14%Strong BuyUnlock the IRD analyst price target with TipRanks PremiumDE:1OT vs IRDUnlock the IRD top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.70$165.09M-0.8928.79%Moderate BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:1OT vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
IKTInhibikase Therapeutics$1.52$214.61M-3.41-5.00%Strong BuyUnlock the IKT analyst price target with TipRanks PremiumDE:1OT vs IKTUnlock the IKT top-analyst price target with TipRanks Premium
SRZNSurrozen$31.61$603.68M-0.72160.81%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:1OT vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
BMEABiomea Fusion$0.58$40.90M-1.84-54.88%Strong BuyUnlock the BMEA analyst price target with TipRanks PremiumDE:1OT vs BMEAUnlock the BMEA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1OTOvid Therapeutics2.301.33137.11%
IRDOpus Genetics3.982.10111.70%
ZNTLZentalis Pharmaceuticals1.700.3727.82%
IKTInhibikase Therapeutics1.52-0.01-0.65%
SRZNSurrozen31.6118.63143.53%
BMEABiomea Fusion0.58-0.70-54.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts